Neurocrine Biosciences, Inc.

Company News

Neurocrine Biosciences and Jnana Therapeutics Enter Strategic Collaboration to Discover Novel Medicines to Treat Central Nervous System Disorders

Partnership Leverages Neurocrine's Expertise in Neuroscience and Jnana's Proprietary Drug Discovery Platform Targeting the Solute Carrier Family of Transporters SAN DIEGO and BOSTON, Oct. 9, 2018 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) and Jnana Therapeutics Inc. today announced that they have entered into a research collaboration aimed at discovering novel small...

Read More »
Company News

Neurocrine Biosciences to Present at the 36th Annual J.P. Morgan Healthcare Conference

Live Audio Webcast Will be on January 8, 2018 SAN DIEGO, Jan. 2, 2018 - Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the 36th Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT (6:00 p.m. ET) on Monday, Jan. 8, 2018, in San Francisco. Kevin Gorman, CEO of Neurocrine Biosciences, will present at the conference. The live presentation will be webcast and may be accessed on the...

Read More »

All Topics